✦ LIBER ✦

Long-term follow-up of patients ≥60 yr old with acute myeloid leukaemia treated with intensive chemotherapy : A randomised trial of aclarubicin vs. daunorubicin in combination with cytosine arabinoside and thioguanine

✍ Scribed by G. Öberg; A. Killander; M. Björeman; G. Gahrton; G. Grimfors; A. Gruber; R. Hast; R. Lerner; J. Liliemark; S. Mattson; C. Paul; B. Simonsson; A.-M. Stalfelt; L. Stenke; U. Tidefelt; A.-M. Udén; M. Björkholm; ( Leukaemia Group of Middle Sweden ; LGMS

Book ID: 114423075
Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 108 KB
Volume: 68
Category: Article
ISSN: 0902-4441
DOI: 10.1034/j.1600-0609.2002.00423.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term survival and development of se

Long-term survival and development of secondary malignancies in patients with acute myeloid leukemia treated with aclarubicin or daunorubicin plus cytosine arabinoside followed by intensive consolidation chemotherapy in a Danish national phase III trial

✍ de Nully Brown, P; Hoffmann, T; Hansen, O P; Boesen, A M; Grønbæk, K; Hippe, E; 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB